Organization Profile

You just read:

In a Phase 3 Trial, Zonovate® Provided Long-term Efficacy and Safety in the Prophylaxis and Treatment of Bleeds in People with Haemophilia A

News provided by

Novo Nordisk

Jun 24, 2015, 07:35 ET